SWOG to conduct immunotherapy clinical trial to treat rare cancers

SWOG, a part of National Cancer Institute ’s National Clinical Trials Network and the NCI Community Oncology Research Programme, has launched the DART immunotherapy trial of ipilimumab and nivolumab (Opdivo) to treat rare cancers.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news